Ilmarinen Mutual Pension Insurance Co Sells 3,000 Shares of McKesson Corporation $MCK

Ilmarinen Mutual Pension Insurance Co cut its stake in McKesson Corporation (NYSE:MCK – Free Report) by 16.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,600 shares of the company’s stock after selling 3,000 shares during the quarter. Ilmarinen Mutual Pension Insurance Co’s holdings in McKesson were worth $13,319,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of MCK. Secure Asset Management LLC lifted its holdings in shares of McKesson by 484.8% in the 2nd quarter. Secure Asset Management LLC now owns 2,123 shares of the company’s stock worth $1,604,000 after acquiring an additional 1,760 shares during the last quarter. Mawer Investment Management Ltd. boosted its stake in shares of McKesson by 5.7% during the 3rd quarter. Mawer Investment Management Ltd. now owns 190,817 shares of the company’s stock worth $162,921,000 after purchasing an additional 10,368 shares during the period. BayBridge Capital Group LLC grew its holdings in McKesson by 268.0% during the 2nd quarter. BayBridge Capital Group LLC now owns 1,943 shares of the company’s stock valued at $1,468,000 after purchasing an additional 1,415 shares during the last quarter. Royal London Asset Management Ltd. grew its holdings in McKesson by 1.1% during the 2nd quarter. Royal London Asset Management Ltd. now owns 112,241 shares of the company’s stock valued at $84,809,000 after purchasing an additional 1,216 shares during the last quarter. Finally, Benchmark Investment Advisors LLC bought a new position in McKesson during the 2nd quarter valued at about $441,000. 85.07% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have issued reports on MCK shares. Argus raised their price objective on shares of McKesson from $850.00 to $970.00 and gave the stock a “buy” rating in a research note on Thursday, September 3rd. Leerink Partners upped their target price on McKesson from $1,070.00 to $1,200.00 and gave the company an “outperform” rating in a research note on Thursday, November 5th. Robert W. Baird set a $1,015.00 target price on McKesson in a research note on Thursday, August 6th. Barclays increased their price target on McKesson from $1,000.00 to $1,235.00 and gave the stock an “overweight” rating in a report on Wednesday. Finally, Wall Street Zen raised McKesson from a “hold” rating to a “buy” rating in a research note on Saturday, October 17th. Fifteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $1,054.12.

Get Our Latest Stock Analysis on MCK

McKesson Trading Up 0.7%

NYSE MCK opened at $1,069.31 on Friday. The company’s 50-day moving average price is $974.65 and its 200-day moving average price is $880.71. The stock has a market cap of $123.46 billion, a PE ratio of 27.50, a PEG ratio of 1.87 and a beta of 0.27. McKesson Corporation has a 12 month low of $723.68 and a 12 month high of $1,121.50.

McKesson (NYSE:MCK – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The company reported $11.68 earnings per share for the quarter, beating analysts’ consensus estimates of $10.72 by $0.96. The company had revenue of $110.96 billion during the quarter, compared to analyst estimates of $109.90 billion. McKesson had a net margin of 1.12% and a negative return on equity of 202.94%. The firm’s revenue for the quarter was up 7.5% on a year-over-year basis. During the same quarter last year, the business posted $9.86 EPS. As a group, sell-side analysts forecast that McKesson Corporation will post 46.09 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be paid a $0.94 dividend. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $3.76 annualized dividend and a yield of 0.4%. McKesson’s dividend payout ratio is 9.67%.

Top McKesson Stories

These are some of the MCK stories that stood out recently:

Insider Activity at McKesson

In other McKesson news, EVP Francisco Fraga sold 800 shares of the firm’s stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $995.80, for a total transaction of $796,640.00. Following the transaction, the executive vice president directly owned 5,423 shares in the company, valued at $5,400,223.40. This trade represents a 12.86% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO B Jr sold 111 shares of McKesson stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total value of $98,950.95. Following the sale, the chief accounting officer directly owned 521 shares of the company’s stock, valued at approximately $464,445.45. This trade represents a 17.56% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 2,161 shares of company stock worth $2,242,515. 0.06% of the stock is owned by insiders.

McKesson Profile

(Free Report)

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.

See Also

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.